Aesara

AESARA
Europe

Your European market access agency.

AESARA
Europe

Your European market access agency.

What We Do

We stay ahead of HTA policy and reimbursement trends to help innovator biotechs succeed in European markets.

  • European market access
  • EU HTAR readiness
  • Reimbursement due diligence
  • Payer & HCP research & advisory boards
  • Value & access function design, optimization & training

What We Do

We stay ahead of HTA policy and reimbursement trends to help innovator biotechs succeed in European markets.

European market access

EU HTAR readiness

Reimbursement due diligence

Payer & HCP research & advisory boards

Value & access function design, optimization & training

What We Offer

We help you answer key business questions such as:

How can we get our product reimbursed in Europe?

What evidence do we need to show value in Europe?

How do we get through European HTA?

How can our drug get a good price in Europe?

What should we invest in Europe – and when?

What We Offer

We help you answer key business questions such as:

How can we get our product
reimbursed in Europe?

What evidence do we need to
show value in Europe?

How do we get through
European HTA?

How can our drug get a
good price in Europe?

What should we invest in
Europe – and when?

Who We Are

We are a unique blend of industry veteran access strategists; value evidence scientists; and creative graphic designers.

Who We Are

We are a unique blend of industry veteran access strategists; value evidence scientists; and creative graphic designers.

Track Record

Our leadership team has held industry-based executive positions within HEOR/MA

from small biotech to large pharmaceutical companies.

Present in all 4 major European markets

4 principal consultants with over 100 years industry experience

>$12bn in deal value in last 12 months for acquisitions of AESARA-supported products

Experience in rare genetic disorders, infectious diseases, neuroscience, oncology etc.

Track Record

Our leadership team has held industry-based executive positions within HEOR/MA from small biotech to large pharmaceutical companies.

Present in all 4 major European markets

4 principal consultants with over 100 years industry experience

>$12bn in deal value in last 12 months for acquisitions of AESARA-supported products

Experience in rare genetic disorders, infectious diseases, neuroscience, oncology etc.